Berkshire Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $738K | Hold |
10,565
| – | – | 0.03% | 160 |
|
|
2025
Q1 | $711K | Hold |
10,565
| – | – | 0.03% | 162 |
|
|
2024
Q4 | $730K | Hold |
10,565
| – | – | 0.03% | 165 |
|
|
2024
Q3 | $824K | Hold |
10,565
| – | – | 0.04% | 148 |
|
|
2024
Q2 | $824K | Hold |
10,565
| – | – | 0.04% | 149 |
|
|
2024
Q1 | $716K | Hold |
10,565
| – | – | 0.04% | 134 |
|
|
2023
Q4 | $712K | Hold |
10,565
| – | – | 0.04% | 130 |
|
|
2023
Q3 | $715K | Hold |
10,565
| – | – | 0.04% | 128 |
|
|
2023
Q2 | $756K | Hold |
10,565
| – | – | 0.04% | 125 |
|
|
2023
Q1 | $733K | Hold |
10,565
| – | – | 0.05% | 124 |
|
|
2022
Q4 | $716K | Hold |
10,565
| – | – | 0.05% | 106 |
|
|
2022
Q3 | $579K | Sell |
10,565
-21
| -0.2% | -$1.15K | 0.04% | 126 |
|
|
2022
Q2 | $699K | Buy |
10,586
+21
| +0.2% | +$1.39K | 0.05% | 124 |
|
|
2022
Q1 | $701K | Hold |
10,565
| – | – | 0.04% | 117 |
|
|
2021
Q4 | $615K | Hold |
10,565
| – | – | 0.04% | 152 |
|
|
2021
Q3 | $635K | Hold |
10,565
| – | – | 0.04% | 143 |
|
|
2021
Q2 | $633K | Hold |
10,565
| – | – | 0.04% | 143 |
|
|
2021
Q1 | $525K | Sell |
10,565
-24
| -0.2% | -$1.19K | 0.04% | 148 |
|
|
2020
Q4 | $529K | Buy |
+10,589
| New | +$529K | 0.04% | 146 |
|
|
2020
Q2 | – | Sell |
-20,898
| Closed | -$933K | – | 171 |
|
|
2020
Q1 | $933K | Buy |
+20,898
| New | +$933K | 0.1% | 105 |
|